Level One Partners
1
22M
1
- Areas of investment
Summary
Among the various public portfolio startups of the fund, we may underline Candel We can highlight the next thriving fund investment areas, such as Medical, Health Care. Besides, a startup requires to be at the age of 16-20 years to receive the investment from the fund.
The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2019.
The typical case for the fund is to invest in rounds with 4 participants. Despite the Level One Partners, startups are often financed by PBM Capital Group, National Securities Corporation. The meaningful sponsors for the fund in investment in the same round are Sands Capital Ventures, Northpond Ventures, H7 Holdings.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Investments by industry
- Therapeutics (1)
- Medical (1)
- Biotechnology (1)
- Health Care (1)
- Genetics (1) Show 1 more
- Investments by region
-
- United States (1)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 23
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Candel | 01 Apr 2019 | Biotechnology, Health Care, Health Diagnostics, Genetics, Medical, Therapeutics | Late Stage Venture | 22M | United States, Massachusetts |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.